Te Ahumairangi Investment Management LTD Gilead Sciences, Inc. Transaction History

Te Ahumairangi Investment Management LTD

$473 Million
Q1 2025

A detailed history of Te Ahumairangi Investment Management LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Te Ahumairangi Investment Management LTD holds 49,752 shares of GILD stock, worth $5.28 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

49,752

Previous 56,621 12.13%

Holding current value

$5.28 Million

Previous $5.23 Million 6.6%

% of portfolio

1.18%

Previous 1.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$89.14 - $117.41 $612,302 - $806,489	-6,869 Reduced 12.13%	49,752 $5.58 Million
Q4 2024 Feb 12, 2025	SELL	$83.95 - $97.9 $2.03 Million - $2.36 Million	-24,145 Reduced 29.9%	56,621 $5.23 Million
Q3 2024 Nov 21, 2024	SELL	$66.59 - $83.99 $638,398 - $805,212	-9,587 Reduced 10.61%	80,766 $6.73 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $101,671 - $117,336	-1,610 Reduced 1.75%	90,353 $6.2 Million
Q1 2024 May 09, 2024	BUY	$71.58 - $87.29 $235,498 - $287,184	3,290 Added 3.71%	91,963 $6.74 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $2.07 Million - $2.34 Million	-28,200 Reduced 24.13%	88,673 $7.18 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $902,068 - $984,174	-12,200 Reduced 9.45%	116,873 $8.76 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $1.23 Million - $1.4 Million	16,185 Added 14.34%	129,073 $9.95 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $660,304 - $752,291	8,541 Added 8.19%	112,888 $9.37 Million
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $1.36 Million - $1.96 Million	-21,865 Reduced 17.32%	104,347 $8.96 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $1.44 Million - $1.64 Million	-24,145 Reduced 16.06%	126,212 $7.79 Million
Q2 2022 Aug 16, 2022	SELL	$57.72 - $65.01 $15,584 - $17,552	-270 Reduced 0.18%	150,357 $9.29 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $846,790 - $1.06 Million	14,620 Added 10.75%	150,627 $8.96 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $648,800 - $736,400	10,000 Added 7.94%	136,007 $9.88 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $270,760 - $292,120	-4,000 Reduced 3.08%	126,007 $8.8 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $602,965 - $658,825	-9,500 Reduced 6.81%	130,007 $8.95 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $1.74 Million - $1.99 Million	29,000 Added 26.24%	139,507 $9.02 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $1.26 Million - $1.44 Million	22,300 Added 25.28%	110,507 $6.44 Million
Q3 2020 Nov 17, 2020	BUY	$62.1 - $78.08 $5.48 Million - $6.89 Million	88,207 New	88,207 $5.57 Million

Others Institutions Holding GILD

# of Institutions

2,288

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $133B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Te Ahumairangi Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Te Ahumairangi Investment Management LTD with notifications on news.

Account

Te Ahumairangi Investment Management LTD Gilead Sciences, Inc. Transaction History